Private equity firm Sentinel Capital Partners has sold WellSpring Consumer Healthcare, a marketer of leading consumer health brands, the firm said. Terms of the deal were not disclosed.
Wellspring manages brands that include Bactine and Emetrol.
“WellSpring owns iconic brands with strong leadership positions,” said John Van Sickle, a Sentinel partner. “WellSpring’s OTC business is a proven M&A platform with a compelling financial profile and a meaningful runway for future growth. Moreover, a fertile M&A environment has produced a large supply of high quality, actionable add-on acquisitions.”
Sentinel will continue to own WellSpring’s contract manufacturing business, the company said.